Tourmaline Bio, Inc. (TRML)

NASDAQ: TRML · Real-Time Price · USD

15.14

+0.03 (0.20%)

May 22, 2025, 12:51 PM - Market open

Tourmaline Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	389	520	532	-	-
Market Cap Growth	-33.48%	-2.33%	-	-	-
Enterprise Value	140	238	583	-	-
Last Close Price	15.11	20.28	26.18	-	-
PB Ratio	1.39	1.73	2.60	-	-
P/TBV Ratio	1.39	1.73	2.60	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.07	-0.66
Quick Ratio	32.71	28.99	40.57	6.06	0.40
Current Ratio	33.87	30.18	41.76	6.10	0.40
Return on Equity (ROE)	-26.14%	-28.99%	-39.66%	-549.77%	-
Return on Assets (ROA)	-19.03%	-21.60%	-25.87%	-266.29%	-
Return on Capital (ROIC)	-19.39%	-22.18%	-26.60%	-314.87%	-
Earnings Yield	-21.28%	-14.08%	-7.91%	-	-
FCF Yield	-21.58%	-14.86%	-5.29%	-	-
Buyback Yield / Dilution	-144.29%	-433.98%	-441.28%	91.94%	-

Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q